Mitochondrial DNA copy number in cervical exfoliated cells and risk of cervical cancer among HPV-positive women
Background Although human papillomavirus (HPV) infection has been recognized as the cause of cervical cancer in over 99% of cases, only a minority of HPV-infected women develop this malignancy. Emerging evidence suggests that alterations of mitochondrial DNA copy number (mtCN) may contribute to carcinogenesis. However, the relationship between mtCN and cervical cancer remains unknown.
Methods In this case-control study, we included 591 cervical cancer cases and 373 cancer-free controls, all of whom were infected with high-risk HPV. Relative mtCN in cervical cancer exfoliated cells was measured by qRT-PCR assays, and logistic regression analysis was performed to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Interaction between mtCN and HPV types was assessed by using the Wald test in logistic regression models.
Results HPV16, 18, 52, and 58 were the most common types in both case and control groups. Median mtCN in cases was significantly higher than that in controls (1.63 vs. 1.23, P = 0.03). After adjustment for age and HPV types, the highest quartile of mtCN was associated with increased odds of having cervical cancer (OR = 1.77, 95% CI = 1.19, 2.62; P < 0.01), as compared to the lowest quartile. A dose-response effect of mtCN on cervical cancer was also observed (Ptrend < 0.001). The interaction between mtCN and HPV types was statistically nonsignificant.
Conclusions In women who test HPV positive, the increase of mtCN in cervical exfoliated cells is associated with cervical cancer. This suggests a potential role of mtCN in cervical carcinogenesis.
Figure 1
Posted 18 Jun, 2020
On 02 Jul, 2020
On 17 Jun, 2020
On 15 Jun, 2020
On 25 May, 2020
On 24 May, 2020
On 24 May, 2020
On 21 May, 2020
On 21 Feb, 2020
Invitations sent on 05 Feb, 2020
On 28 Jan, 2020
On 27 Jan, 2020
On 27 Jan, 2020
On 19 Jan, 2020
Received 18 Jan, 2020
On 08 Jan, 2020
Received 07 Jan, 2020
On 24 Dec, 2019
On 23 Dec, 2019
Invitations sent on 23 Dec, 2019
On 22 Dec, 2019
On 22 Dec, 2019
Received 25 Nov, 2019
On 25 Nov, 2019
Received 23 Nov, 2019
On 08 Nov, 2019
On 04 Nov, 2019
Invitations sent on 30 Oct, 2019
On 28 Oct, 2019
On 25 Oct, 2019
On 24 Oct, 2019
On 20 Oct, 2019
Mitochondrial DNA copy number in cervical exfoliated cells and risk of cervical cancer among HPV-positive women
Posted 18 Jun, 2020
On 02 Jul, 2020
On 17 Jun, 2020
On 15 Jun, 2020
On 25 May, 2020
On 24 May, 2020
On 24 May, 2020
On 21 May, 2020
On 21 Feb, 2020
Invitations sent on 05 Feb, 2020
On 28 Jan, 2020
On 27 Jan, 2020
On 27 Jan, 2020
On 19 Jan, 2020
Received 18 Jan, 2020
On 08 Jan, 2020
Received 07 Jan, 2020
On 24 Dec, 2019
On 23 Dec, 2019
Invitations sent on 23 Dec, 2019
On 22 Dec, 2019
On 22 Dec, 2019
Received 25 Nov, 2019
On 25 Nov, 2019
Received 23 Nov, 2019
On 08 Nov, 2019
On 04 Nov, 2019
Invitations sent on 30 Oct, 2019
On 28 Oct, 2019
On 25 Oct, 2019
On 24 Oct, 2019
On 20 Oct, 2019
Background Although human papillomavirus (HPV) infection has been recognized as the cause of cervical cancer in over 99% of cases, only a minority of HPV-infected women develop this malignancy. Emerging evidence suggests that alterations of mitochondrial DNA copy number (mtCN) may contribute to carcinogenesis. However, the relationship between mtCN and cervical cancer remains unknown.
Methods In this case-control study, we included 591 cervical cancer cases and 373 cancer-free controls, all of whom were infected with high-risk HPV. Relative mtCN in cervical cancer exfoliated cells was measured by qRT-PCR assays, and logistic regression analysis was performed to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Interaction between mtCN and HPV types was assessed by using the Wald test in logistic regression models.
Results HPV16, 18, 52, and 58 were the most common types in both case and control groups. Median mtCN in cases was significantly higher than that in controls (1.63 vs. 1.23, P = 0.03). After adjustment for age and HPV types, the highest quartile of mtCN was associated with increased odds of having cervical cancer (OR = 1.77, 95% CI = 1.19, 2.62; P < 0.01), as compared to the lowest quartile. A dose-response effect of mtCN on cervical cancer was also observed (Ptrend < 0.001). The interaction between mtCN and HPV types was statistically nonsignificant.
Conclusions In women who test HPV positive, the increase of mtCN in cervical exfoliated cells is associated with cervical cancer. This suggests a potential role of mtCN in cervical carcinogenesis.
Figure 1